Rebuilding Tolerance: An iPSC-Derived Thymic Cell Therapy for the Restoration of Immune Tolerance

• Exploring the thymus – the central organ responsible for establishing and maintaining immune tolerance
• Development of iPSC – derived thymic cells that demonstrate in vivo T cell education to re-establish central tolerance in immune-related diseases
• Unlocking the potential of thymus – based regenerative medicine to restore immune balance

Speakers:

Yeh-Chuin Poh

Vice President Head of Technical Operations

Tolerance Bio